NYSEMKT: NNVCNanoviricides Inc Stock Ownership - Who owns Nanoviricides?
Insider buying vs selling
Have Nanoviricides Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when NNVC insiders and whales buy or sell their stock.
NNVC Shareholders
What type of owners hold Nanoviricides Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Theracour Pharma Inc | 282.88% | 33,321,000 | $37.99M | Insider |
| Milton Boniuk | 128.70% | 15,159,145 | $17.28M | Insider |
| Anil Diwan | 17.36% | 2,044,918 | $2.33M | Insider |
| Eugene Seymour | 10.60% | 1,248,814 | $1.42M | Insider |
| Vanguard Group Inc | 3.89% | 458,416 | $522.59k | Institution |
| Meeta Vyas | 3.73% | 439,570 | $501.11k | Insider |
| Blackrock Inc | 1.35% | 159,297 | $181.60k | Institution |
| Compagnie Lombard Odier Scma | 1.27% | 150,000 | $171.00k | Institution |
| Geode Capital Management LLC | 0.93% | 109,489 | $124.82k | Institution |
| Renaissance Technologies LLC | 0.67% | 78,500 | $89.49k | Institution |
NNVC vs Biotech Stocks
Nanoviricides Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.